Date Action Amount Person Type
Feb 14, 2024 Buy 150 000 Ashe Andrew D. Stock Option (right to buy)
Feb 14, 2024 Buy 36 000 Ashe Andrew D. Restricted Stock Units
Feb 14, 2024 Buy 526 000 Kathiresan Sekar Stock Option (right to buy)
Feb 14, 2024 Buy 132 000 Kathiresan Sekar Restricted Stock Units
Feb 14, 2024 Buy 125 000 Nickerson Joan Stock Option (right to buy)
Feb 14, 2024 Buy 24 000 Nickerson Joan Restricted Stock Units
Feb 14, 2024 Buy 90 000 Fiedorek Fred T. Stock Option (right to buy)
Feb 14, 2024 Buy 22 000 Fiedorek Fred T. Restricted Stock Units
Feb 14, 2024 Buy 180 000 Dorval Allison Stock Option (right to buy)
Feb 14, 2024 Buy 45 000 Dorval Allison Restricted Stock Units
Feb 14, 2024 Buy 180 000 Bellinger Andrew Stock Option (right to buy)
Feb 14, 2024 Buy 45 000 Bellinger Andrew Restricted Stock Units
Dec 31, 2023 Buy 0 Adelman Burt A
Dec 01, 2023 Buy 0 Gv 2023 Gp, L.l.c. Common Stock
Dec 01, 2023 Buy 1 800 000 Yeshwant Krishna Common Stock
Nov 29, 2023 Buy 1 875 Dorval Allison Common Stock
Nov 29, 2023 Sell 554 Dorval Allison Common Stock
Nov 29, 2023 Sell 1 875 Dorval Allison Restricted Stock Units
Sep 18, 2023 Buy 180 000 Fiedorek Fred T. Stock Option (right to buy)
Sep 18, 2023 Buy 0 Fiedorek Fred T.
Jun 15, 2023 Buy 26 642 Maclean Michael F Stock Option (right to buy)
Jun 15, 2023 Buy 26 642 Cumbo Alexander Stock Option (right to buy)
Jun 15, 2023 Buy 26 642 Yeshwant Krishna Stock Option (right to buy)
Jun 15, 2023 Buy 26 642 Adelman Burt A Stock Option (right to buy)
Jun 15, 2023 Buy 26 642 Coats Lonnel Stock Option (right to buy)
Jun 15, 2023 Buy 26 642 Mikhail Sheila Stock Option (right to buy)
Feb 15, 2023 Buy 0 Nickerson Joan Common Stock
Feb 15, 2023 Buy 69 000 Nickerson Joan Stock Option (right to buy)
Feb 15, 2023 Buy 102 016 Nickerson Joan Stock Option (right to buy)
Feb 15, 2023 Buy 53 170 Nickerson Joan Stock Option (right to buy)
Feb 15, 2023 Buy 13 260 Nickerson Joan Restricted Stock Units
Feb 14, 2023 Buy 182 800 Bellinger Andrew Stock Option (right to buy)
Feb 14, 2023 Buy 182 800 Dorval Allison Stock Option (right to buy)
Feb 14, 2023 Buy 550 200 Kathiresan Sekar Stock Option (right to buy)
Feb 14, 2023 Buy 7 000 Maclean Michael F Stock Option (right to buy)
Feb 14, 2023 Buy 182 800 Ashe Andrew D. Stock Option (right to buy)
Dec 14, 2022 Sell 36 000 Bellinger Andrew Stock Option (right to buy)
Dec 14, 2022 Buy 36 000 Bellinger Andrew Common Stock
Dec 01, 2022 Sell 865 Bellinger Andrew Common Stock
Nov 29, 2022 Sell 1 875 Dorval Allison Restricted Stock Units
Nov 29, 2022 Buy 1 875 Dorval Allison Common Stock
Nov 29, 2022 Sell 554 Dorval Allison Common Stock
Nov 04, 2022 Sell 48 583 Yeshwant Krishna Common Stock
Nov 04, 2022 Sell 47 690 Yeshwant Krishna Common Stock
Nov 04, 2022 Sell 650 Yeshwant Krishna Common Stock
Nov 04, 2022 Sell 243 Yeshwant Krishna Common Stock
Nov 04, 2022 Sell 48 583 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 48 583 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 47 690 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 47 690 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 650 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 650 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 243 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 243 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 47 690 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 47 690 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 651 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 651 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 242 Gv 2017 Gp, L.l.c. Common Stock
Nov 04, 2022 Sell 242 Gv 2017 Gp, L.l.c. Common Stock
Nov 03, 2022 Sell 49 569 Yeshwant Krishna Common Stock
Nov 03, 2022 Sell 22 279 Yeshwant Krishna Common Stock
Nov 03, 2022 Sell 25 534 Yeshwant Krishna Common Stock
Nov 03, 2022 Sell 1 755 Yeshwant Krishna Common Stock
Nov 03, 2022 Sell 49 569 Gv 2017 Gp, L.l.c. Common Stock
Nov 03, 2022 Sell 22 279 Gv 2017 Gp, L.l.c. Common Stock
Nov 03, 2022 Sell 25 534 Gv 2017 Gp, L.l.c. Common Stock
Nov 03, 2022 Sell 1 755 Gv 2017 Gp, L.l.c. Common Stock
Nov 03, 2022 Sell 22 279 Gv 2017 Gp, L.l.c. Common Stock
Nov 03, 2022 Sell 25 535 Gv 2017 Gp, L.l.c. Common Stock
Nov 03, 2022 Sell 1 755 Gv 2017 Gp, L.l.c. Common Stock
Nov 02, 2022 Sell 28 651 Yeshwant Krishna Common Stock
Nov 02, 2022 Sell 9 350 Yeshwant Krishna Common Stock
Nov 02, 2022 Sell 10 372 Yeshwant Krishna Common Stock
Nov 02, 2022 Sell 8 930 Yeshwant Krishna Common Stock
Nov 02, 2022 Sell 28 651 Gv 2017 Gp, L.l.c. Common Stock
Nov 02, 2022 Sell 9 350 Gv 2017 Gp, L.l.c. Common Stock
Nov 02, 2022 Sell 10 372 Gv 2017 Gp, L.l.c. Common Stock
Nov 02, 2022 Sell 8 930 Gv 2017 Gp, L.l.c. Common Stock
Nov 02, 2022 Sell 9 349 Gv 2017 Gp, L.l.c. Common Stock
Nov 02, 2022 Sell 10 372 Gv 2017 Gp, L.l.c. Common Stock
Nov 01, 2022 Sell 31 963 Yeshwant Krishna Common Stock
Nov 01, 2022 Sell 29 326 Yeshwant Krishna Common Stock
Nov 01, 2022 Sell 2 377 Yeshwant Krishna Common Stock
Nov 01, 2022 Sell 260 Yeshwant Krishna Common Stock
Nov 01, 2022 Sell 31 963 Gv 2017 Gp, L.l.c. Common Stock
Nov 01, 2022 Sell 29 326 Gv 2017 Gp, L.l.c. Common Stock
Nov 01, 2022 Sell 2 377 Gv 2017 Gp, L.l.c. Common Stock
Nov 01, 2022 Sell 260 Gv 2017 Gp, L.l.c. Common Stock
Oct 31, 2022 Sell 53 697 Yeshwant Krishna Common Stock
Oct 31, 2022 Sell 23 732 Yeshwant Krishna Common Stock
Oct 31, 2022 Sell 23 275 Yeshwant Krishna Common Stock
Oct 31, 2022 Sell 6 601 Yeshwant Krishna Common Stock
Oct 31, 2022 Sell 88 Yeshwant Krishna Common Stock
Oct 31, 2022 Sell 53 697 Gv 2017 Gp, L.l.c. Common Stock
Oct 31, 2022 Sell 23 732 Gv 2017 Gp, L.l.c. Common Stock
Oct 31, 2022 Sell 23 275 Gv 2017 Gp, L.l.c. Common Stock
Oct 31, 2022 Sell 6 601 Gv 2017 Gp, L.l.c. Common Stock
Oct 31, 2022 Sell 88 Gv 2017 Gp, L.l.c. Common Stock
Oct 31, 2022 Sell 23 732 Gv 2017 Gp, L.l.c. Common Stock
INSIDER POWER
77.295
Last 100 transactions
Buy: 5 077 648 | Sell: 1 178 927 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 77.295.

In total, the insiders bought 5 077 648 and sold 1 178 927 VERV shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT